FDA Approved Medical Products for:
The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.
(Biomarin Pharmaceutical Inc.)
The FDA has approved this product to be used in this manner.
|Indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information